Suppliers / Katwijk Chemie

Katwijk Chemie

Netherlands Updated 9 July 2026

Katwijk Chemie is an API manufacturer based in Netherlands. It holds 4 active US drug master files across a filed portfolio of 8 molecules.

4
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Ethosuximide SFDA (Saudi Arabia), US FDA 2
Deferiprone SFDA (Saudi Arabia) 1
Oxaprozin US FDA 1
Pemoline US FDA 1
Phenytoin SFDA (Saudi Arabia) 1
Sodium Divalproate SFDA (Saudi Arabia) 1
Sodium Valproate SFDA (Saudi Arabia) 1
Valproic Acid US FDA 1

Also appears on these molecule pages

Deferiprone API Phenytoin API Sodium Valproate API Valproic Acid API

Questions about Katwijk Chemie

Does Katwijk Chemie hold a US DMF or a CEP?
Katwijk Chemie holds 4 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Katwijk Chemie make?
8 molecules are on record against Katwijk Chemie, including Ethosuximide, Deferiprone, Oxaprozin and Pemoline. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Checking Katwijk Chemie?

Ask Fred what the record holds on Katwijk Chemie, including filings and inspection history.

Chat with Fred, your AI analyst
Opens WhatsApp. Free to start.

Comparable suppliers

Harman Finochem shares 3 molecules Sanofi Winthrop Industrie shares 2 molecules Sci Pharmtech shares 2 molecules Assurgen Pharma shares 2 molecules Apotex shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability